Bioxcel Therapeutics share price logo

Bioxcel Therapeutics Share Price

NASDAQ: BTAI

Small Cap

$4.22

+0.43

(+11.48%)

as on

Bioxcel Therapeutics Stock Performance

as on September 9, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $3.76
    $4.29
    downward going graph

    10.90%

    Downside

    1.66%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.17
    $13.36
    downward going graph

    72.27%

    Downside

    216.63%

    Upside

    downward going graph

Bioxcel Therapeutics share price movements today

Previous Close
$3.79
Open
$3.78
Volume
2.4M
Day's Low - High
$3.76 - $4.29
52 Week Low - High
$1.17 - $13.36

Bioxcel Therapeutics Historical Returns

1 Month Return
-6.19 %
3 Month Return
+ 105.98 %
1 Year Return
-56.65 %
3 Year Return
-98.43 %
5 Year Return
-99.44 %

Bioxcel Therapeutics Stock Fundamentals & Key Indicators

Check Bioxcel Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$55.2M

EPS (TTM)

-5.43

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.24

Industry PE ratio

-197.17

P/B Ratio

0

PEG Ratio

0

EBITDA

-49.8M

Revenue (TTM)

868.0K

Profit Margin

0.00%

Return On Equity TTM

1337600.00%

Bioxcel Therapeutics Stock Valuation

Track how Bioxcel Therapeutics P/E has moved over time to understand its valuation trends.

Bioxcel Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 8, 2025

Industry (-197.17x)

September 8, 2025

Today (-0.24x)

September 8, 2025

Highest (-0.67x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.24x

Bioxcel Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bioxcel Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$55.2M-99.44%-0.240.00%
NA$39.2BNANA-3.89%
BUY$59.2B267.51%-505.15-12.96%
BUY$101.6B53.17%28.1731.86%
BUY$60.8B2.04%14.4531.37%

Stock Returns calculator for Bioxcel Therapeutics Stock including INR - Dollar returns

The Bioxcel Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Bioxcel Therapeutics investment value today

Current value as on today

₹53,070

Returns

₹46,930

(-46.93%)

Returns from Bioxcel Therapeutics Stock

₹51,716 (-51.72%)

Dollar Returns*

₹4,786 (+4.79%)

Analyst Recommendation on Bioxcel Therapeutics Stock

Based on 13 analysts

BUY

69.23%

Buy

30.77%

Hold

0.00%

Sell

Based on 13 analysts, 69.23% of analysts recommend a 'BUY' rating for Bioxcel Therapeutics. Average target price of $19.4

Bioxcel Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Bioxcel Therapeutics.

What analysts predicted

78.25%UPSIDE

Target Price

$19.4

Current Price

$4.22

Analyzed by

13 Analysts

Target

$19.40

Bioxcel Therapeutics target price $19.4, a slight upside of 78.25% compared to current price of $4.22. According to 13 analysts rating.

Bioxcel Therapeutics Stock's Interest Amongst Investors

Investment in Bioxcel Therapeutics Shares on INDmoney has grown by 64.70% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:64.70% versus previous 30 day period

Search interest for Bioxcel Therapeutics Stock has increased by 119% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:119% versus previous 30 day period

Bioxcel Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
0
0
0
0
0
1
0
0
0
0
Gross Profit
0
0
0
0
0
1
0
0
0
0
Operating Income
-51
-52
-48
-19
-23
-17
-15
-10
-13
-15
EBITDA
-49
-50
-47
-18
-23
-4
-9
-6
-6
-15
Interest Expense
3
3
3
3
3
3
3
4
3
4
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-52
-53
-50
-22
-26
-8
-13
-10
-7
-19
Income Tax Expense
-1
3
3
-5
0
0
-
-
-
-
Net Income
-51
-53
-50
-22
-26
-8
-13
-10
-7
-19
Net Profit Margin
-24770.39%
-11710.07%
-14805.28%
-5919.15%
-4603.26%
-751.72%
-6378.50%
-2966.94%
-4317.86%
-15989.17%

Bioxcel Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
0
-
0
1
2
Gross Profit
-
0
0
0
0
0
0
0
0
Operating Income
-2
-4
-19
-33
-82
-106
-159
-171
-67
EBITDA
-2
-4
-19
-32
-82
-106
-157
-165
-44
Interest Expense
-
0
-
-
0
0
8
13
15
Depreciation
-
0
0
0
0
0
0
0
0
Income Before Tax
-2
-4
-19
-32
-82
-106
-165
-179
-59
Income Tax Expense
-2
-
0
0
0
0
6
0
-
Net Income
-2
-4
-19
-32
-82
-106
-165
-179
-59
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-337481481.48%
0.00%
-44201.87%
-12974.86%
-2630.14%

Bioxcel Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-53
-50
-22
-26
-8
-13
-10
-7
-19
Operating Cash Flow
-38
-37
-26
-17
-23
-16
-14
-12
-12
Investing Cash Flow
0
-
-
-
-
-
-
-
-
Financing Cash Flow
0
0
2
26
5
0
4
13
0
Change in Cash
-37
-37
-24
8
-17
-15
-10
1
-12

Bioxcel Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-2
-4
-19
-32
-82
-106
-165
-179
-59
Operating Cash Flow
-1
-2
-13
-27
-66
-82
-135
-155
-72
Investing Cash Flow
0
0
0
0
0
0
0
0
-
Financing Cash Flow
1
3
55
18
247
102
96
26
36
Change in Cash
1
0
41
-10
180
19
-39
-128
-35

Global Institutional Holdings in Bioxcel Therapeutics

Funds
Holdings
Murchinson Ltd.
2.25%
UBS Group AG
1.68%
Goldman Sachs Group Inc
0.41%
BlackRock Inc
0.38%
Geode Capital Management, LLC
0.36%

Insights on Bioxcel Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, BTAI stock has moved up by 106.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 83.2% return, outperforming this stock by 139.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Beone Medicines Ltd has given 99.7% return, outperforming this stock by 198.1%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 366.0K → 120.0K (in $), with an average decrease of 41.3% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -7.25M → -19.18M (in $), with an average decrease of 164.5% per quarter

About Bioxcel Therapeutics

bioxcel therapeutics, inc. is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology. the company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. the company's two most advanced clinical development programs are bxcl501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and bxcl701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer.
OrganisationBioxcel Therapeutics
Headquarters555 Long Wharf Drive, New Haven, CT, United States, 06511
IndustryHealth Technology
CEODr. Vimal D. Mehta Ph.D.
E-voting on sharesClick here to vote

Key Management of Bioxcel Therapeutics

Name

Title

Dr. Vimal D. Mehta Ph.D.

Founder, CEO, President, & Director

Mr. Richard I. Steinhart MBA

Senior VP & CFO

Mr. Javier Rodriguez J.D.

Senior VP, Chief Legal Officer & Corporate Secretary

Dr. Frank D. Yocca Ph.D.

Executive VP & Chief Scientific Officer

FAQs

What is Bioxcel Therapeutics share price today?

Bioxcel Therapeutics share price today is $4.22 as on at the close of the market. Bioxcel Therapeutics share today touched a day high of $4.29 and a low of $3.76.

What is the 52 week high and 52 week low for Bioxcel Therapeutics share?

Bioxcel Therapeutics share touched a 52 week high of $13.36 on and a 52 week low of $1.17 on . Bioxcel Therapeutics stock price today i.e. is closed at $4.22,which is 68.42% down from its 52 week high and 260.68% up from its 52 week low.

What is Bioxcel Therapeutics's market capitalisation today?

Bioxcel Therapeutics market capitalisation is $0.00T as on .

How to invest in Bioxcel Therapeutics Stock (BTAI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bioxcel Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bioxcel Therapeutics Shares that will get you 0.3555 shares as per Bioxcel Therapeutics share price of $4.22 per share as on September 9, 2025 at 1:29 am IST.

What is the minimum amount required to buy Bioxcel Therapeutics Stock (BTAI) from India?

Indian investors can start investing in Bioxcel Therapeutics (BTAI) shares with as little as ₹88.008 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.08 in Bioxcel Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Bioxcel Therapeutics share’s latest price of $4.22 as on September 9, 2025 at 1:29 am IST, you will get 2.3697 shares of Bioxcel Therapeutics. Learn more about fractional shares .

What are the returns that Bioxcel Therapeutics has given to Indian investors in the last 5 years?

Bioxcel Therapeutics stock has given -99.44% share price returns and 19.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?